Sotagliflozin is effective in reducing heart failure risk of events in patients with HFpEF
14 May 2024 (10:19 - 10:27)
Organised by: 
About the speaker
Lexicon Pharmaceuticals, Inc., The Woodlands (United States of America)
6 More presentations in this session
Miss B. Goovaerts (Antwerp, BE)
Professor J. Cleland (Glasgow, GB)
Assistant Professor P. Becher (Hamburg, DE)
Doctor D. Garcia Vega (Ourense, ES)
Access the full session
The Event
Heart Failure 2024
14 May 2024
10:19 CET
You may be interested in
Congress Session
